
Advisory: Nutrition Priorities for GLP-1 Use in Obesity
METHODOLOGY:
An expert group comprised of multiple clinical and research disciplines assessed the literature to identify pragmatic priorities for nutrition and other lifestyle interventions relevant to GLP-1 treatment for obesity.
Based on the group's findings, The Obesity Society, American College of Lifestyle Medicine, American Society for Nutrition, and the Obesity Medicine Association simultaneously published 'Nutritional Priorities to Support GLP-1 Therapy for Obesity' in their own peer-reviewed journals.
The consensus-based clinical advisory reflects an interdisciplinary collaboration to help clinicians support patients receiving GLP-1 treatment with evidence-based nutritional and behavioral strategies.
TAKEAWAY:
The expert group found that GLP-1s reduced body weight by 5%-18% in trials, with modestly lower effects in real-world analyses, and multiple clinical benefits.
Challenges included side effects, especially gastrointestinal (GI); nutritional deficiencies due to calorie reduction; muscle and bone loss; low long-term adherence and subsequent weight regain; as well as high costs resulting in low cost-effectiveness.
The group recommended eight priorities to address the challenges: (1) Patient-centered initiation of therapy; (2) careful baseline nutritional assessment; (3) management of GI side effects, (4) personalized, nutrient-dense, minimally processed diets; (5) prevention of micronutrient deficiencies; (6) adequate protein intake and strength training to preserve lean mass; (7) leveraging a good diet to maximize weight reduction; and (8) promoting other lifestyle changes around activity, sleep, mental stress, substance use, and social connections to maximize long-term success.
IN PRACTICE:
'Medical therapy for obesity and lifestyle changes go and-in-hand,' Marc-Andre Cornier, MD, The Obesity Society president, said in an accompanying press release. 'This guidance lays a nutrition roadmap to help providers support their patients on sustainable and lasting weight reduction journeys. It underscores the importance of nutrition on quality of life and is an important contribution to the literature about incorporating lifestyle interventions into obesity care.'
SOURCE:
The clinical advisory, led by Advisory Chair Dariush Mozaffarian, MD, DrPH, of Tufts University, Boston, was published simultaneously in Obesity , American Journal of Lifestyle Medicine , The American Journal of Clinical Nutrition , and Obesity Pillars .
LIMITATIONS:
Recommendations are based on a literature review and a consensus among expert group members.
DISCLOSURES:
Mozaffarian reported research funding from the National Institutes of Health, Kaiser Permanente Fund at the East Bay Community Foundation, National Association of Chain Drug Stores Foundation, Google Health, and The Rockefeller Foundation; scientific advisory board, Beren Therapeutics, Brightseed, Calibrate, Elysium Health, Filtricine, HumanCo, Instacart Health, January Inc., WndrHLTH; scientific consulting, Amazon Health; equity in Calibrate and HumanCo; and chapter royalties from UpToDate.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
Trump, tech giants want to make it easier to share health records: What it means for you
President Donald Trump and his top health officials are pursuing a new initiative that will allow people to share their personal health and medical records with doctors and hospitals. Technology giants Apple, Amazon, Google and Open AI as well as health industries companies UnitedHealth Group and CVS Health are among more than 60 companies that have agreed to develop standards to share health information across computer systems. Trump touted the idea of eliminating redundancies such as filling out paperwork at multiple health providers offices. "This will allow patients to easily transmit information from one doctor to another," Trump said during a July 30 briefing with Health and Human Services Secretary Robert F. Kennedy Jr. and Centers for Medicare & Medicaid Services Administrator Mehmet Oz. Trump emphasized the initiative will be voluntary and require patients to opt in. He added there will be no centralized, government-run database storing patients' personal records. "People are very concerned about the personal records," Trump said. "That's their choice ... it will be absolutely quiet." Large hospital systems and some doctors allow patients to share health information, fill out forms and schedule appointments through websites and mobile apps. And health tech companies have developed apps that allow people to track their health information, but these apps often can't access medical records from health providers, said Amy Gleason, acting administrator of the Department of Government Efficiency, or DOGE. Companies operating 21 networks have agreed to an "interoperability framework" to meet Centers for Medicare & Medicaid Services criteria, according to the Trump administration. Hospital systems and electronic health records vendors have agreed to cooperate in the effort, according to CMS. Participating apps would help people manage obesity and diabetes, including the use of AI assistants to help check symptoms or schedule appointments, CMS said. Privacy, data security remain top worries The health care industry and tech companies have been attempting to reduce paperwork and seamlessly share electronic health records for three decades, said Chris Pierson, CEO of BlackCloak, an Orlando, Florida-based cybersecurity company. Hospitals, doctors, labs and vendors that directly handle such sensitive medical records are subject to a federal privacy law, called the Health Insurance Portability and Accountability Act, or HIPAA. To make health information and records more portable and accessible, consumers need to be guaranteed strong privacy protections and granted control over what information is shared, Pierson said. A consumer might be willing to share their sensitive information with doctors, hospitals or labs. But the same person might want to block an app from sharing records with third parties such as exercise equipment vendors or nutritional supplement retailers. Pierson said such apps would likely still need to comply with HIPAA and other federal and state laws. Given that the apps are voluntary and require consent, they likely would comply with privacy laws, Pierson said. Companies also would need to safeguard information technology security to protect the sensitive information from data breaches. Hackers target health records Digital medical records are a popular target for hackers seeking sensitive health information, bank records and a person's identifiable information such as dates of birth and Social Security numbers. The number of attacks has surged in recent years and are often carried out by organized hackers, often operating overseas, who target the computer systems of health providers and the vendors and companies that serve them. HHS investigates whether breaches involve violations of health information privacy and security laws and publicly reports attacks that affect 500 or more on its website. In July alone, more than two dozen data breaches compromised the records of more than 3 million people, HHS records show. The largest hack in recent years involved the February 2024 attack on UnitedHealth-owned subsidiary Change Healthcare. The attack disrupted the health care industry because doctors and hospitals were unable to collect payments for weeks when computer systems went down. This article originally appeared on USA TODAY: Trump plan eases sharing of computerized health records Solve the daily Crossword

Wall Street Journal
9 minutes ago
- Wall Street Journal
The Big Beautiful Bill's Healthcare Opportunity
Health-insurance companies have long dictated which doctors Americans can consult, trapping patients in narrow networks and bureaucratic red tape. The One Big Beautiful Bill Act breaks that monopoly. By loosening the grip of insurers and empowering families with greater choice and flexibility, this bold reform restores control to patients. Most Americans pay for medical care through traditional health insurance provided by their employer or through the individual market. This system puts insurers in charge of determining which physicians and facilities families can visit, often through network restrictions and prior-authorization barriers. It also forces healthcare providers to spend large sums of money on billing departments to request and negotiate payments from health insurers. One 2009 study estimates that physician practices spent 13% of their revenue on administrative overhead for insurance billing and reimbursement. Every dollar that healthcare providers spend on their billing departments shows up in higher prices.

Wall Street Journal
9 minutes ago
- Wall Street Journal
Novo Nordisk's Weight Loss Lesson
Talk about dropping weight fast. See Novo Nordisk's 33.8% stock plunge this past week after it reduced its sales forecast. The Ozempic manufacturer has shed hundreds of billions of dollars in market value over the last year amid stepped-up competition. One lesson is that pharmaceutical cash cows rarely last long. Novo Nordisk slashed its profit forecast owing to slower sales growth for its Ozempic diabetes and Wegovy weight-loss treatments in the U.S. Its blockbuster GLP-1 drugs have been losing market share to Eli Lilly's Mounjaro and Zepbound. The latter has shown greater weight loss than Wegovy in some studies. Lilly is also building on its success with an experimental drug that can increase weight loss from fat and reduce loss of lean muscle mass. Its experimental once-a-day pill has shown comparable efficacy to Ozempic's weekly injectable. A pill would be less expensive to manufacture and more popular among patients. Both Lilly and Novo Nordisk previously struggled to scale up manufacturing to meet enormous demand for their weight-loss drugs. Under Food and Drug Administration rules, specialty pharmacies are allowed to produce knock-offs of drugs on its shortage list. Although the FDA has removed the drugs from its shortage list, some pharmacies continue to manufacturer them.